Abstract
Racial disparities impacting management of psoriasis patients are incompletely understood. The objective of this study was to assess biologic discontinuation and switching rates after 6-months of therapy among psoriasis patients of different racial/ethnic backgrounds in the US/Canadian CorEvitas Psoriasis Registry. This study included patients who initiated a biologic between April 2015-March 2021 and had a known treatment status at 6-months follow-up. Patient characteristics at initiation were compared by race/ethnicity.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
